A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy

Clinical Rehabilitation

Volumn 23, Issue 9, 2009, Pages 800-811

  Xu, Kaishou ^a   Yan, Tiebin ^a   Mai, Jianning ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Children's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ANKLE PLANTAR FLEXOR SPASTICITY; ARTICLE; CEREBRAL PALSY; CHILD; CHINESE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COMPOSITE SPASTICITY SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ELECTRICAL STIMULATION INJECTION; FEMALE; FUNCTIONAL STATUS; GAIT; GROSS MOTOR FUUNCTION MEASURE; HEMIPLEGIA; HUMAN; INJECTION; INTERMETHOD COMPARISON; LEG MOVEMENT; MAJOR CLINICAL STUDY; MALE; MODIFIED ASHWORTH SCALE; OUTCOME ASSESSMENT; PALPATION INJECTION; PASSIVE MOVEMENT; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; SINGLE BLIND PROCEDURE; SPASTICITY; TREATMENT RESPONSE; WALKING SPEED;

BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES; RANGE OF MOTION, ARTICULAR;

EID: 69849084423     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269215509335295     Document Type: Article

References (36)

1. Lin Q., Li S., Liu J. et al. Prevalence and clinical classification of cerebral palsy of children in 6 provinces or autonomous region in China. Chin J Pediatr 2001; 39: 613-15.
2. Gage JR Gait analysis in cerebral palsy. London, MacKeith Press, 1991, 37-117.
3. Miller F. Physical therapy of cerebral palsy. New York, Springer, 2007, 345-68.
4. Tilton AH Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol 2004; 11: 58-65.
5. Diamond M. Rehabilitation strategies for the child with cerebral palsy. Pediatr Ann 1986; 15: 230-4.
6. Botte MJ, Abrams RA, Bodine-Fowler SC Treatment of acquired muscle spasticity using phenol peripheral nerve blocks. Orthopedics 1995; 18: 151-9.
7. Ubhia T., Bhakta BB, Ives HL, Allgar V., Roussounis SH Randomized double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83: 481-7.
8. Reddihough DS, King JA, Coleman GJ et al. Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol 2002; 44: 820-7.
9. El-Etribi MA, Salem ME, El-Shakankiry HM The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: An Egyptian study. Int J Rehabil Res 2004; 27: 275-81.
10. Koman LA, Paterson SB, Balkrishnan R. Spasticity associated with cerebral palsy in children: Guidelines for the use of botulinum A toxin. Paediatr Drugs 2003; 5: 11-23.
11. Naumann M., Jankovic J. Safety of botulinum toxin type A: A systematic review and meta-analysis. Curr Med Res Opin 2004; 20: 981-90.
12. Graham HK, Aoki KR, Autti-Rämö I. et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11: 67-79.
13. Lannin N., Scheinberg A., Clark K. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections. Dev Med Child Neurol 2006; 48: 533-9.
14. Cardoso ES, Rodrigues BM, Barroso M. et al. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Pediatr Neurol 2006; 34: 106-109.
15. Boyd RN, Hays RM Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: A systematic review. Eur J Neurol 2001; 8: S1-20.
16. Ade-Hall RA, Moore AP Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database Syst Rev 2000; 2: CD001408.
17. Simpson DM, Gracies JM, Graham HK et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70: 1691-8.
18. Morton RE, Hankinson J., Nicholson J. Botulinum toxin for cerebral palsy; where are we now? Arch Dis Child 2004; 89: 1133-7.
19. Jefferson RJ Botulinum toxin in the management of cerebral palsy. Dev Med Child Neurol 2004; 46: 491-9.
20. Kinnett D. Botulinum toxin A injections in children: Technique and dosing issues. Am J Phys Med Rehabil 2004; 83: 59-64.
21. Childers MK Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil 2004; 83: S38-44.
22. Berweck S., Schroeder AS, Fietzek UM, Heinen F. Sonography-guided injection of botulinum toxin in children with cerebral palsy. Lancet 2004; 363: 249-50.
23. Singhi P., Ray M. Botulinum toxin in children with cerebral palsy. Indian J Pediatr 2004; 71: 1087-91.
24. Jensen CV A computer program for randomizing patients with near-even distribution of important parameters. Comput Biomed Res 1991; 24: 429-34.
25. Bohannon RW, Smith MB Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
26. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C., Hardy S., Jarvis S. The gross motor function measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989; 31:341-52.
27. Wood E., Rosenbaum PL The Gross Motor Function Classification System for cerebral palsy: A study of reliability and stability over time. Dev Med Child Neurol 2000; 42: 292-6.
28. Levin MF, Hui-Chan CWY. Relief of hemiparetic spasticity by TENS is associated with improvement in reflex and voluntary motor functions. Electroencephalogr Clin Neurophysiol 1992; 85: 131-42.
29. O'Neil ME, Fragala MA, Dumas HM Physical therapy intervention for children with cerebral palsy who receive botulinum toxin A injections. Pediatr Phys Ther 2003; 15: 204-15.
30. Damiano DL Activity, activity, activity: Rethinking our physical therapy approach to cerebral palsy. Phys Ther 2006; 86: 1534-40.
31. Cosgrove AP, Graham HK Botulinum toxin A prevents the development of contractures in the heredity spastic mouse. Dev Med Child Neurol 1994; 36: 379-85.
32. Slawek J., Klimont L. Functional improvement in cerebral palsy patients treated with botulinum toxin A injections preliminary results. Eur J Neurol 2003; 10: 313-17.
33. El O., Peker O., Kosay C., Iyilikci L., Bozan O., Berk H. Botulinum toxin a injection for spasticity in diplegic-type cerebral palsy. J Child Neurol 2006; 21: 1009-12.
34. Childers MK The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Phys Med Rehabil Clin N Am 2003; 14: 781-92.
35. Chin TY, Nattrass GR, Selber P., Graham HK Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 2005; 25: 286-91.
36. Koman LA, Mooney JF, Smith BP, Walker F., Leon JM Botulinum toxin type A neuromuscular blockade in the treatment of lower limb spasticity in cerebral palsy: A randomized double-blind placebo controlled trial. J Pediatr Orthop 2000; 20: 108-15.